Prevalence of Schistosoma mansoni infection in Ethiopia: a systematic review and meta-analysis.

IF 2.4 Q3 INFECTIOUS DISEASES
Siraj Hussen, Demissie Assegu, Birkneh Tilahun Tadesse, Techalew Shimelis
{"title":"Prevalence of Schistosoma mansoni infection in Ethiopia: a systematic review and meta-analysis.","authors":"Siraj Hussen,&nbsp;Demissie Assegu,&nbsp;Birkneh Tilahun Tadesse,&nbsp;Techalew Shimelis","doi":"10.1186/s40794-020-00127-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Schistosomiasis is a common helminthic infection in the tropics and subtropics, particularly in sub-Saharan African countries including Ethiopia. In these counties, Schistosoma mansoni infection is a significant public health problem due to the risk of reinfection and recurrent disease despite implementing several rounds preventive chemotherapy. This systematic review and meta-analysis aimed at assessing the pooled prevalence of schistosomiasis in Ethiopia.</p><p><strong>Methods: </strong>The PRISMA guidelines were followed to perform the systematic review and meta-analysis. Published studies from January 1999 to June 2020 were searched in Medline, PubMed, Google Scholar, EMBASE, HINARI, and Cochrane Library using key words including: \"prevalence\", \"incidence\", \"schistosomiasis\" \"Bilharziasis\", \"Bilharzia\", \"S. mansoni \", \"Ethiopia\". Heterogeneity of included studies was assessed using Cochran's Q test and I<sup>2</sup> test statistics while publication bias was assessed using Egger's test.</p><p><strong>Results: </strong>Ninety-four studies were included in the systematic review and meta-analysis. The pooled prevalence of S. mansoni in Ethiopia was 18.0% (95%CI: 14.0-23.0). The southern region of Ethiopia had a higher S. mansoni prevalence of 25.9% (995% CI, 14.9-41.1) than the national prevalence. The burden of S. mansoni infection was also higher than the national average in rural areas and among men with pooled prevalence of 20.2% (95% CI, 13.2-28.5) and 28.5% (95%CI, 22.7,35.1), respectively. The trend analysis showed that the prevalence of S. mansoni infection in Ethiopia decreased over the past 15 years, potentially because of the repeated preventive chemotherapy.</p><p><strong>Conclusion: </strong>The review unveiled a moderate prevalence of S. mansoni infection in Ethiopia. Targeted treatment of at-risk population groups ad high burden areas coupled with implementation of integrated vector control strategies are critical to address the burden of Schistosomiasis.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40794-020-00127-x","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tropical Diseases, Travel Medicine and Vaccines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40794-020-00127-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 15

Abstract

Background: Schistosomiasis is a common helminthic infection in the tropics and subtropics, particularly in sub-Saharan African countries including Ethiopia. In these counties, Schistosoma mansoni infection is a significant public health problem due to the risk of reinfection and recurrent disease despite implementing several rounds preventive chemotherapy. This systematic review and meta-analysis aimed at assessing the pooled prevalence of schistosomiasis in Ethiopia.

Methods: The PRISMA guidelines were followed to perform the systematic review and meta-analysis. Published studies from January 1999 to June 2020 were searched in Medline, PubMed, Google Scholar, EMBASE, HINARI, and Cochrane Library using key words including: "prevalence", "incidence", "schistosomiasis" "Bilharziasis", "Bilharzia", "S. mansoni ", "Ethiopia". Heterogeneity of included studies was assessed using Cochran's Q test and I2 test statistics while publication bias was assessed using Egger's test.

Results: Ninety-four studies were included in the systematic review and meta-analysis. The pooled prevalence of S. mansoni in Ethiopia was 18.0% (95%CI: 14.0-23.0). The southern region of Ethiopia had a higher S. mansoni prevalence of 25.9% (995% CI, 14.9-41.1) than the national prevalence. The burden of S. mansoni infection was also higher than the national average in rural areas and among men with pooled prevalence of 20.2% (95% CI, 13.2-28.5) and 28.5% (95%CI, 22.7,35.1), respectively. The trend analysis showed that the prevalence of S. mansoni infection in Ethiopia decreased over the past 15 years, potentially because of the repeated preventive chemotherapy.

Conclusion: The review unveiled a moderate prevalence of S. mansoni infection in Ethiopia. Targeted treatment of at-risk population groups ad high burden areas coupled with implementation of integrated vector control strategies are critical to address the burden of Schistosomiasis.

Abstract Image

Abstract Image

Abstract Image

埃塞俄比亚曼氏血吸虫感染流行:系统回顾和荟萃分析。
背景:血吸虫病是热带和亚热带地区常见的寄生虫感染,特别是在包括埃塞俄比亚在内的撒哈拉以南非洲国家。在这些县,尽管实施了几轮预防性化疗,但由于再次感染和疾病复发的风险,曼氏血吸虫感染是一个重大的公共卫生问题。本系统综述和荟萃分析旨在评估埃塞俄比亚血吸虫病的总流行率。方法:采用PRISMA指南进行系统评价和meta分析。检索1999年1月至2020年6月在Medline、PubMed、Google Scholar、EMBASE、HINARI和Cochrane Library中发表的研究,关键词包括:“患病率”、“发病率”、“血吸虫病”、“Bilharziasis”、“bilharziia”、“S. mansoni”、“埃塞俄比亚”。采用Cochran’s Q检验和I2检验统计量评估纳入研究的异质性,采用Egger检验评估发表偏倚。结果:94项研究被纳入系统评价和荟萃分析。埃塞俄比亚曼索尼血吸虫的总流行率为18.0% (95%CI: 14.0-23.0)。埃塞俄比亚南部地区的曼索尼沙门氏菌患病率为25.9% (995% CI, 14.9-41.1),高于全国患病率。农村地区和男性的曼氏链球菌感染负担也高于全国平均水平,总患病率分别为20.2% (95%CI, 13.2-28.5)和28.5% (95%CI, 22.7,35.1)。趋势分析显示,在过去15年中,埃塞俄比亚的曼索尼沙门氏菌感染率有所下降,这可能是由于反复的预防性化疗。结论:回顾揭示了一个中等流行的曼索尼沙门氏菌感染在埃塞俄比亚。有针对性地治疗高危人群和高负担地区,同时实施综合病媒控制战略,对于解决血吸虫病负担至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.20
自引率
0.00%
发文量
25
审稿时长
17 weeks
期刊介绍: Tropical Diseases, Travel Medicine and Vaccines is an open access journal that considers basic, translational and applied research, as well as reviews and commentary, related to the prevention and management of healthcare and diseases in international travelers. Given the changes in demographic trends of travelers globally, as well as the epidemiological transitions which many countries are experiencing, the journal considers non-infectious problems including chronic disease among target populations of interest as well as infectious diseases.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信